Johnson & Johnson Vaccine News: Live Global Updates on Covid-19

Preparation of vaccine doses in Munich last month.  The Johnson & amp;  The deployment of the Johnson vaccine has been suspended in the European Union.

[]).push(function () { viAPItag.display(“vi_1088641796”) }) || []).push(function () { viAPItag.display(“vi_1088641796”) })

Credit…Kamil Krzaczynski / Agence France-Presse – Getty Images

For federal health officials, asking states on Tuesday to suspend use of the Johnson & Johnson coronavirus vaccine until they can investigate six extremely rare but worrying cases of blood clots was an obvious decision and may -be inevitable.

But where scientists saw caution, public health officials saw a tricky trade-off: Blood clotting so far only appears to affect one in every million people injected with the vaccine, and it doesn’t. is not yet clear whether the vaccine is the cause. If the evidence for coagulation increases vaccine reluctance and helps conspiracy theorists, the “break” could ultimately make – and even kill – more people sick than it saves.

“It’s a messaging nightmare,” said Rachael Piltch-Loeb, health risk communication expert at the NYU School of Global Public Health. But officials had no other ethical option, she added. “To ignore it would sow the seeds of the growing sense that public health officials are lying to the public.”

Johnson & Johnson’s single-dose vaccine was just starting to gain traction among doctors and patients after its reputation was hit by early clinical trials suggesting its protection against the coronavirus was not as strong as that of vaccines manufactured by Pfizer-BioNTech and Moderna. Before Tuesday’s break, some patients were asking for it by name.

But amid the storm of news and social media attention surrounding the hiatus, those gains may well be lost, especially if the rare blood clotting fuels conspiracy theorists and political opponents, who seemed to be losing ground as they went. that the vaccination rate was increasing.

The problem explains the relative risk, said Rupali J. Limaye, who studies public health messages at the Johns Hopkins Bloomberg School of Public Health. She noted that the potential rate of blood clotting in response to the vaccine is much lower than the rate of blood clotting in cigarette smokers or in women who use hormonal contraception, although the types of clots differ.

And officials don’t “shoot” the vaccine. They are just asking for a timeout, in fact, to determine how best to use it.

The vaccines were already answering questions from worried patients on Tuesday.

Maulik Joshi, president and CEO of Meritus Health in Hagerstown, Md., Which administered 50,000 doses of the three vaccines without any major reactions reported, said he had a simple message to allay patient fears: “It’s a good thing they put it on hiatus, and that’s science at work. “

Jennifer Steinhauer, Madeleine Ngoand Hailey Fuchs contribution to reports.

Credit…Tomohiro Ohsumi / Getty Images

Organizers marked 100 days before the start of the Tokyo Olympics on Wednesday with a subdued ceremony amid tighter restrictions and growing questions about the event as Japan suffers a new wave of coronavirus infections.

Tokyo Governor Yuriko Koike has promised officials will do anything to organize a “tournament to remember.” Wearing a mask and gloves, she unveiled statues of the Olympic mascots inside the Tokyo government building while a video link showed another group of officials unveiling a monument of the Olympic rings atop Mount Takao shrouded in fog, 48 km west of the capital.

But parts of Tokyo and other municipalities remain under a near-state of emergency ordered last week to stem what authorities are calling the fourth wave of infections in Japan. Japan has recorded nearly 3,200 infections per day over the past week, according to a New York Times database – few by US and European standards, but a worrying number for Asia .

The host country is also lagging behind in terms of vaccinations: vaccines for these 65 years have just started on Monday. So far, Japan has only vaccinated frontline medical workers, who make up less than 1% of the population, and it will be far from being fully vaccinated on July 23, the date scheduled for the Games to start.

Japan calls them the “Olympic Games of the revival” – highlighting the nation’s recovery from the devastating earthquake, tsunami and nuclear disaster of 2011, as well as the recovery of the world from the pandemic. But the Games, originally scheduled for last year, are continuing despite more than 70% of the Japanese public saying they should be postponed again or canceled entirely.

Organizers announced last month that international spectators would be banned, although thousands of athletes from more than 200 nations are expected to compete. The ceremonial torch relay made its way through Japan with little fanfare; his two-day stop in Osaka this week was diverted from public roads and took place in an empty park.

Credit…Laetitia Vancon for the New York Times

It was first AstraZeneca. Now Johnson & Johnson.

Last week, British regulators and the European Union’s medical agency said they had established a possible link between AstraZeneca’s Covid-19 vaccine and very rare, although sometimes fatal, blood clots.

The break in use of Johnson & Johnson’s vaccine in Europe amid similar concerns threatens to hamper a slow rollout that was just beginning to gain momentum, after months of supply shortages and logistical challenges.

Regulators have asked vaccines and doctors to look for certain symptoms, including severe and persistent headaches and tiny spots of blood under the skin. Groups of doctors have disseminated advice on how to treat the disorder.

According to a YouGov poll published last month, 61% of French people, 55% of Germans and 52% of Spaniards consider the AstraZeneca vaccine to be “dangerous”.

Almost everywhere in the European Union, many are hungry for alternatives. Moderna and Pfizer vaccines, based on different technology, have not been associated with similar side effects.

Although all EU countries have been offered a part of every vaccine approved in the block so far – AstraZeneca, Johnson & Johnson, Moderna and Pfizer – many have chosen to forgo part of their vaccine share more expensive or bulkier like Pfizer and Moderna from the start, instead favoring the AstraZeneca jab.

“In Britain or Eastern Europe a lot of the campaigns are based on AstraZeneca,” said Yves Van Laethem, a senior epidemiologist who is the spokesperson for the Belgian Covid task force.

The wealthiest members of the bloc like Denmark, France, Germany and the Netherlands may better compensate for the loss of confidence in AstraZeneca, as they have acquired additional doses of other vaccines – especially Pfizer – via a secondary market after the poorest countries in the EU abandoned theirs.

But these countries – including Bulgaria, Croatia, Latvia and Slovakia – will likely be less able to come up with alternatives quickly.

Raphael Minder contribution to reports.

The Heliix Health Passport uses an encrypted code to display the results of a recent Covid test or vaccination.
Credit…Ethan Miller / Getty Images

As all American adults will soon be eligible for Covid-19 vaccines and businesses, and international borders reopen, a fierce debate has started across the United States over whether a digital health certificate (often and mistakenly called a “vaccination passport”) should be required to prove vaccination status.

Currently, Americans are given a white paper card as proof of their Covid-19 injections. But these can easily be forged, and online crooks are already selling fake and stolen vaccine cards.

Although the federal government has said it will not introduce digital vaccine passports by federal warrant, a growing number of companies say they will need proof of vaccination for entry or services.

The campaign raised issues of confidentiality and fairness. States like Florida and Texas have banned companies from requiring vaccination certificates.

Governments, tech companies, airlines and other companies are testing different versions of digital health passes and trying to come up with common standards so that there is compatibility between each system and health records can be reviewed. safely retrieved.

Here is what we know.

At this time, only if you live in New York. Last month, it became the first state in the United States to launch a digital health certificate called the Excelsior Pass, which checks a person’s negative coronavirus test result and whether they are fully vaccinated.

Some airlines, including Lufthansa, Virgin Atlantic and Jet Blue, have started using the digital health app, Common Pass, to verify test results of Covid-19 passengers before boarding flights.

It depends on national regulations. The Biden administration said there would be no vaccination system or federal mandate. Individual states hold primary public health authority in the United States and have the authority to require vaccines.

All states except New Hampshire have their own immunization registries and some cities, such as New York, have theirs.

Currently, states are required to share their records with the Centers for Disease Control and Prevention, but the data is not public and could be withheld.

“There are many valid concerns about how privacy and technology would work with these systems, especially since Silicon Valley does not have a lot of experience in delivering technology that enhances privacy,” said Brian Behlendorf, executive director of the Linux Foundation Public Health, an open-source, technology-driven organization.

Some argue that such accreditation would infringe on personal freedoms and private health choices.

Others fear that a digital-only system will leave some communities behind, especially those without access to smartphones or the internet.

The World Health Organization says it does not yet support the requirement for vaccination passports for travel due to uncertainty over whether inoculation prevents transmission of the virus, as well as problems with equity.

[]).push(function () { viAPItag.display(“vi_1088641796”) }) || []).push(function () { viAPItag.display(“vi_1088641796”) })


Please enter your comment!
Please enter your name here